Ebola Virus

Ebola, also known as Ebola hemorrhagic fever or Ebola viral disease, is a rare and deadly illness caused by one of the strains of Ebola virus. This viral agent is regarded as a prototype pathogen of viral hemorrhagic fever, with high fatality rates in humans and primates.
What is Ebola?

Ebola, also known as Ebola hemorrhagic fever or Ebola viral disease, is a rare and deadly illness caused by one of the strains of Ebola virus. This viral agent is regarded as a prototype pathogen of viral hemorrhagic fever, with high fatality rates in humans and primates. The natural reservoir of Ebola virus remains unknown, although bats seem to be the most likely reservoir.

Read More

Overview

Feature Articles

Latest Ebola Virus News and Research

Fourth Phase 3 clinical trial evaluating COVID-19 vaccine begins in the U.S.

Fourth Phase 3 clinical trial evaluating COVID-19 vaccine begins in the U.S.

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

Scientists investigate active plasma metabolite of remdesivir in SARS-CoV-2 mouse model

Scientists investigate active plasma metabolite of remdesivir in SARS-CoV-2 mouse model

3D printed nanoparticle biosensing platform detects SARS-CoV-2 antibodies within seconds

3D printed nanoparticle biosensing platform detects SARS-CoV-2 antibodies within seconds

Study suggests a wider distribution range of Ebola virus carriers in Africa than previously assumed

Study suggests a wider distribution range of Ebola virus carriers in Africa than previously assumed

New cellular pathway protects cells from infection by Ebola virus, coronaviruses

New cellular pathway protects cells from infection by Ebola virus, coronaviruses

NIAID awards $17 million to establish the Centers for Research in Emerging Infectious Diseases

NIAID awards $17 million to establish the Centers for Research in Emerging Infectious Diseases

Italy starts human trials of potential COVID-19 vaccine

Italy starts human trials of potential COVID-19 vaccine

Single dose nasal vaccine against SARS-CoV-2 shows promise in animal studies

Single dose nasal vaccine against SARS-CoV-2 shows promise in animal studies

FDA issues emergency use authorization for convalescent plasma in COVID-19

FDA issues emergency use authorization for convalescent plasma in COVID-19

Nasal vaccine effective in preventing COVID-19 infection in mice

Nasal vaccine effective in preventing COVID-19 infection in mice

Study shows how bats survive the Ebola virus

Study shows how bats survive the Ebola virus

Pigs appear to be immune to SARS-CoV-2

Pigs appear to be immune to SARS-CoV-2

Experimental COVID-19 vaccine prevents severe disease in mice

Experimental COVID-19 vaccine prevents severe disease in mice

Experimental vaccine effective at preventing pneumonia in COVID-19-infected mice

Experimental vaccine effective at preventing pneumonia in COVID-19-infected mice

Zika virus mutation responsible for quick spread, birth defects uncovered

Zika virus mutation responsible for quick spread, birth defects uncovered

Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses

Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses

Ebola survivors have long-lasting severe immune dysfunction

Ebola survivors have long-lasting severe immune dysfunction

Researchers are producing COVID-19 spike proteins to prevent future infections

Researchers are producing COVID-19 spike proteins to prevent future infections

Georgia State professor receives federal funding to study unique features of Ebola, Marburg viruses

Georgia State professor receives federal funding to study unique features of Ebola, Marburg viruses